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Edited by Michael R. BubbAbstract The pathogenesis of severe acute respiratory syn-
drome coronavirus (SARS-CoV) is an important issue for treat-
ment and prevention of SARS. Recently, SARS-CoV 3CLpro
protease has been implied to be possible relevance to SARS-
CoV pathogenesis. In this study, we intended to identify potential
3CLpro-interacting cellular protein(s) using the phage-displayed
human lung cDNA library. The vacuolar-H+ ATPase (V-ATP-
ase) G1 subunit that contained a 3CLpro cleavage site-like motif
was identiﬁed as a 3CLpro-interacting protein, as conﬁrmed using
the co-immunoprecipitation assay and the relative aﬃnity assay.
In addition, our result also demonstrated the cleavage of the V-
ATPase G1 fusion protein and the immunoprecipitation of cellu-
lar V-ATPase G1 by the 3CLpro. Moreover, loading cells with
SNARF-1 pH-sensitive dye showed that the intracellular pH in
3CLpro-expressing cells was signiﬁcantly lower as compared to
mock cells.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Severe acute respiratory syndrome-associated coronavirus
(SARS-CoV) causes bronchial epithelial denudation, loss of ci-
lia, and multinucleated in lung tissues [1,2], and induces lym-
phopenia, leucopenia, and thrombocytopenia in the SARS
patients [3,4]. The relevance to SARS-CoV pathogenesis be-
comes an attractive issue for developing anti-SARS therapy.
SARS-CoV contains a single positive-stranded RNA genome
that is approximately 30 kb in length and has a 5 0 cap structure
and 3 0 polyA tract [5–7]. The SARS-CoV genome encodes for
replicase, spike, envelope, membrane, and nucleocapsid. The
replicase gene encodes two large overlapping polypeptides
(replicase 1a and 1ab, 450 and 750 kD, respectively),
including 3C-like protease (3CLpro), RNA-dependent RNA
polymerase, and RNA helicase for viral replication and tran-
scription [8]. The SARS-CoV 3CLpro mediates the proteolytic
processing of replicase polypeptides 1a and 1ab into functional*Corresponding author. Fax: +886 4 22057414.
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In the case of picornaviruses, poliovirus, enterovirus 71, and
rhinovirus, 3C protease have been demonstrated to cleave spe-
ciﬁc cellular proteins [9,10], inhibit the cellular translation
[11,12], and induce cell apoptosis [13–15]. Recently, SARS-
CoV 3CLpro cleavage sites have been predicted in cellular pro-
teins such as the cystic ﬁbrosis transmembrane conductance
regulator, and transcription factors CREB-RP and OCT-1
using computational methods [16], signifying SARS-CoV
3CLpro protease can be involved in virus-induced pathology.
In this study, we intended to identify potential 3CLpro-interact-
ing cellular protein(s) using the phage-displayed human lung
cDNA library.2. Materials and methods
2.1. Biopanning of phage display lung cDNA libraries with SARS-CoV
3CLpro
The 3CLpro-expressing E. coli strain described in our previous report
[17] was used for generation of recombinant 3CLpro His-tag fusion
protein. For biopanning, the T7Select human lung cDNA library fused
at the C terminus of phage capsid protein 10B was purchased from
Novagen (Madison, WI). Following the biopanning procedure in our
previous report [18], ﬁve rounds of biopanning for screening 3CLpro-
aﬃnity phage clones were carried out using 3CLpro-coated microplates
(5 lg per well). The 3CLpro-aﬃnity phage clones were eluted with the
soluble 3CLpro. For direct ELISA binding assay, the individual eluted
phage clones that were determined using a plaque assay were coated
onto microplates (1010 p.f.u./well) for 1 h at room temperature. After
blocking phage-coated plates, 100 ll of 20 lg/ml 3CLpro was added
to each well for additional 1-h incubation. Bound 3CLpro was detected
using the ELISA with the anti-His tag monoclonal antibody and anti-
mouse IgG antibodies conjugated to peroxidase (Pharmacia). ELISA
product was developed with a chromogen solution containing ABTS
(2,2 0-azino-di-(3-ethylbenzthiazoline-6-sulfonate)) and hydrogen per-
oxide and then measured at A405 nm. The lung cDNA genes displayed
on 3CLpro-aﬃnity phages were directly ampliﬁed using PCR with the
T7 Select UP primer 5 0-GGAGCTGTCGTATTCCAGTCA-30 and
the T7 Select DOWN primer 5 0-CCCCTCAAGACCCGTTTA-30.
The nucleotide sequences of each PCR product were determined using
the sequencing with the ABI PRISM 377 DNA Sequencer (Perkin–El-
mer, USA). The deduced amino acid sequences of 3CLpro-interacting
lung cDNA clones were aligned using the BLAST search (http://
www.ncbi.nlm.nih.gov/BLAST/).
2.2. Co-immunoprecipitation of SARS-CoV 3CLpro protease by
vacuolar-H+ ATPase G1 subunit
For the cell-free co-immunoprecipitation assay, the vacuolar-H+
ATPase gene was cloned into the vector pET32a, and expressed as
the fusion protein with thioredoxin (Trx) at the N-terminus andblished by Elsevier B.V. All rights reserved.
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ATPase subunit G1 displayed on the 3CLpro-aﬃnity phage clone 7
was ampliﬁed by PCR with primers: 5 0-ATCCGAATTCGCCAAG-
GAAGCTGCGG-3 0 and 5 0-CCGCAAGCTTTCCATTTATGCGG-
TAG-3 0. The PCR product was digested with EcoRI and HindIII,
and then cloned into the EcoRI/HindIII site of the expression vector
pET32a (Novagen). The mixture of 3CLpro and vacuolar-H+ ATPase
thioredoxin fusion protein was ﬁrst incubated with anti-thioredoxin
mAb (Invitrogen) for 4 h at 4 C, and then reacted with the protein
A-Sepharose beads for the addition of 2-h incubation. After centrifu-
gation, the pellet was washed four times with NET buﬀer (150 mM
NaCl, 0.1 mM EDTA, 30 mM Tris–HCl, and pH 7.4). The immuno-
precipitate was dissolved in a 2· SDS–PAGE sample buﬀer without
2-mercaptoethanol and boiled for 10 min. Proteins were resolved on
12% SDS–PAGE gels and electrophoretically transferred to nitrocel-
lulose papers. The resultant blots were blocked with 5% skim milk,
and then reacted with the anti-His tag mAb for 1-h incubation.
The blots were then washed with TBS three times and overlaid with
a 1/1000 dilution of rabbit anti-mouse IgG antibodies conjugatedFig. 1. Gel electrophoresis of PCR products (A) and deduced amino acid s
displayed on the identiﬁed phage clones. (A) After ﬁve rounds of biopanning
individual eluted phage plaques were ampliﬁed using PCR. (B) The amino acid
from phage Nos. 7,25,31,32,33,34,35, and 46 was deduced from the human
A dashed-line box was marked for the possible 3CLpro cleavage site.with alkaline phosphatase (KPL). Following another1-h incubation
at room temperature, the blots were developed with NBT/BCIP
(Invitrogen).2.3. ELISA aﬃnity assay
The wells of a 96-well microtiter plate were coated with 100 ll of
5 lg/ml 3CLpro and were incubated at 4 C overnight. Following each
incubation and subsequent layer of the enzyme-linked immunosorbent
assay (ELISA), the wells were washed three times with TBS containing
0.05% Tween 20 (TBST). After blocking with 5% skim milk in TBST,
serial dilution of V-ATPase G1 TRX fusion protein or thioredoxin
(TRX) was incubated in 3CLpro-coated wells for 2 h. The bound V-
ATPase G1 TRX fusion protein or TRX protein was detected with
the anti-TRX monoclonal antibody, and then the ELISA product
was developed with goat anti-mouse IgG-HRP conjugate and ABTS/
H2O2 substrates. The relative aﬃnity, Kd, was estimated from the con-
centration necessary for 50% maximal binding based on a computer
program employing Fishers statistical model.equence (B) from SARS-CoV 3CLpro-interacting human lung proteins
with SARS-CoV 3CLpro, the human lung cDNA clones displayed on
sequence of 3CLpro-interacting human lung protein that was identiﬁed
lung cDNA nucleotide sequence from 3CLpro-interacting phage No. 7.
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The SARS-CoV 3CLpro protease was incubated with the V-ATPase
G1 TRX fusion protein or TRX protein in 100 mM Tri–HCl (pH
9.0) at 37 C. The proteolytic processing was analyzed using Western
blotting with anti-His tag antibody. Band intensities of the V-ATPase
G1 TRX fusion protein or TRX protein on the nitrocellulose were
quantiﬁed by densitometric analysis.
2.5. Immunoprecipitates of cell extract by 3CLpro
The 3CLpro gene was cloned into the pcDNA3.1 vector and gener-
ated as a His-tag fusion protein [17]. The resulting plasmid
pcDNA3.1-SARS CoV 3CLpro (pSARS-CoV 3CLpro) (4.5 lg) plus
indicator vector pEGFP-N1 (0.5 lg) was transfected into HL-CZ cells,
a human promonocyte cell line [19], using the GenePorter reagent. The
cell extract of the 3CLpro-expressing cells and mock cells was incubated
with anti-His tag antibody to 3CLpro for 4 h at 4 C, and then reacted
with the protein A-Sepharose beads for the addition of 2-h incubation.
The immunoprecipitate was analyzed using Coomassie blue staining,
and Western blotting with anti-His tag antibody to 3CLpro and chicken
anti-V-ATPase G1 polyclonal antibody (Chemicon).
2.6. Measurement of intracellular pH in transfected cells with SNARF-1
Transfected cells were washed three times with PBS and incubated
with 20 lM carboxy SNARF-1 (Molecular Probe) for 30 min at room
temperature. Subsequently, the cells were washed with PBS again and
then placed into the microplates. A dual-emission ration at 580 and
640 nm of intracellular dye was detected using a ﬁxed excitation at
514 nm, and then converted to intracellular pH (pHi) according to pre-
vious reports [20].Fig. 2. The speciﬁc interaction of SARS-CoV 3CLpro with V-ATPase
G1 TRX fusion protein using co-immunoprecipitation assay (A) and
the binding aﬃnity assay (B). (A) An equal amount of V-ATPase G1
TRX fusion protein and the SARS-CoV 3CLpro was ﬁrst incubated
with anti-TRX mAb at 4 C overnight, followed by incubation with
the protein A-Sepharose beads for the addition of 2-h incubation.
After centrifugation, the pellet was washed with NET buﬀer, and then
dissolved in 2· SDS–PAGE sample buﬀer without 2-mercaptoethanol
and boiled for 10 min. Following the western blot procedure, the blot
was probed with mouse anti-His tag antibodies, and developed with an
alkaline phosphatase-conjugated secondary antibody and NBT/BCIP
substrates. (B) 100 ll of 5 lg/ml 3CLpro was coated onto 96-well plates;
followed by incubation with the indicated concentration of V-ATPase
G1 TRX fusion protein or thioredoxin (TRX). Bound V-ATPase G1
TRX fusion protein or thioredoxin was detected using anti-TRX
monoclonal antibody. The ELISA product was developed with goat
anti-mouse IgG-HRP conjugate and ABTS/H2O2 substrates.3. Results
3.1. Identiﬁcation of SARS-CoV 3CLpro-interacting lung
protein(s)
For identifying potential 3CLpro-interacting human lung
proteins, aﬃnity selection of a phage-displayed human lung
cDNA library with recombinant 3CLpro protein was carried
out. After ﬁve rounds of biopanning, ﬁfty eluted phage plaques
were selected for determining relative aﬃnities to SARS-CoV
3CLpro using direct binding ELISA assay. Ten of the ﬁfty
phage clones, phage-7,8,25,31,32,33,34,35,45, and 46 had
higher absorbance values of the ELISA product compared to
other phage clones (data not shown here). In addition, these
ten selected phage clones showed approximately 3–5-fold in-
creases in direct ELISA binding compared to the wild type
phage T7. Therefore, these ten identiﬁed phage clones were
suggested to display the high aﬃnity of lung cDNA clones to
SARS-CoV 3CLpro.
Lung cDNA clones displayed on these ten 3CLpro-interact-
ing phages were subsequently ampliﬁed using PCR. Gel elec-
trophoresis of the PCR products revealed that about 400
base pair products were ampliﬁed from eight phage clones,
phage-7,25,31,32,33,34,35, and 46 (Fig. 1A, lanes
2,4,5,6,7,8,9, and 11), and about 300 pair products were
found in two phage clones, phage-8 and 45 (Fig. 1A, lanes 3
and 10). Direct sequencing of the PCR products showed the
same nucleotide sequences of lung cDNA clones displayed
on phage-7,25,31,32,33,34,35, and 46 (Fig. 1B). The BLAST
alignment search indicated that the deduced amino acid se-
quence of the 3CLpro-interacting lung cDNA clone was identi-
cal to the C-terminus of vacuolar ATP synthase subunit G 1
(V-ATPase G1 subunit) (GenBank Accession No. O75348
and NP_004879). Interestingly, V-ATPase G1 contains a motif
Thr-Ile-Leu-Gln-Thr, being similar to the conserved 3CLpro
cleavage sites (Val/Thr)-X-Leu-Gln-(Ser/Ala).3.2. Binding interaction of 3CLpro with V-ATPase G1
To test the speciﬁc interaction of 3CLpro with V-ATPase G1,
the identiﬁed lung cDNA clone encoding for the C-terminus of
V-ATPase G1 subunit was cloned into the bacterial expression
vector pET32a, being generated as a thioredoxin (TRX) and
His-tag fusion protein in E. coli. Co-immunoprecipitation of
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was performed. After centrifugation, the protein complex was
precipitated by the anti-thioredoxin antibody and the protein
A-Sepharose beads. Western blot analysis of the immunopre-
cipitate demonstrated that 3CLpro was precipitated by the V-
ATPase G1 TRX fusion protein (Fig. 2A, lane 5) but not the
TRX protein (Fig. 2A, lane 2). Furthermore, direct binding
of V-ATPase G1 TRX fusion protein to SARS-CoV 3CLpro
showed a dose-dependent manner in the ELISA assay
(Fig. 2B). The relative binding aﬃnity (Kd) of the V-ATPase
G1 TRX fusion protein to recombinant 3CLpro protease was
approximately 1.9 lM, indicating that the V-ATPase G1 sub-
unit was suﬃcient for binding to SARS-CoV 3CLpro.
3.3. Cleavage of V-ATPase G1 by SARS-CoV 3CLpro
Because the V-ATPase G1 contains a possible cleavage site
for 3CLpro, the trans-cleavage reaction of 3CLpro with the V-
ATPase G1 TRX fusion protein was carried out in the alkaline
buﬀer at 37 C. In Western blot analysis with anti-His tag anti-
body, the V-ATPase G1 TRX fusion protein but not the TRX
protein was cleaved by the 3CLpro protease (Fig. 3). Based on
the remaining amount of the V-ATPase G1 TRX fusion pro-
tein, densitometric analysis demonstrated that the percentage
of the cleaved V-ATPase G1 TRX fusion protein reached up
to approximately 70% (Fig. 3, lanes 7–9); however, no signiﬁ-
cant change was found in the amount of the TRX protein
(Fig. 3, lanes 3–5).
3.4. Interaction of SARS-CoV 3CLpro with cellular V-ATPase
G1
To examine the cell-based interaction of SARS-CoV 3CLpro
with V-ATPase G1, the SARS-CoV 3CLpro gene was cloned
into the mammalian expression vector pcDNA3.1, and then
transfected into human promonocyte HL-CZ cells. Western
blotting analysis of cell lysates with anti-His-tag antibody
demonstrated a major 68-kDa band for the dimer and a minor
34-kDa band in the 3CLpro-expressing cells (not shown here).
For further analyzing the binding of cellular V-ATPase G1 to
3CLpro, the cell lysate of the 3CLpro-expressing cells and mock
cells was precipitated by anti-His tag antibody to 3CLpro
(Fig. 4A–C). In the Coomassie-stained gel, the immunoprecip-Fig. 3. Trans-cleavage of V-ATPase G1 TRX fusion protein by SARS-CoV
the V-ATPase G1 TRX fusion protein (lanes 6–9) or TRX protein (lanes 2–5)
was analyzed using Western blotting with anti-His tag antibody. Lane 1, pritate by anti-His tag antibody contained many cellular proteins
from the 3CLpro-expressing cells (Fig. 4A, lane 6), while only a
few proteins from mock cells (Fig. 4A, lane 3). Of the cellular
proteins in the immunoprecipitate, a 68-kDa – immunoreac-
tive band for the dimer 3CLpro was found using Western
blotting with anti-His tag antibody (Fig. 4B, lane 6). In
addition, Western blot analysis with anti-V-ATPase G1 poly-
clonal antibodies demonstrated a major 13-kDa band for
cellular V-ATPase G1 protein in the 3CLpro-precipitated pellet
(Fig. 4C, lane 6). The result conﬁrmed the interaction between
3CLpro and V-ATPase G1 in the HL-CZ cells. Since V-ATPase
in the plasma and lysosomal membranes is the major proton-
extruding molecule for controlling cytosolic pHi [21,22], the
cytosolic pHi in SARS-CoV 3CL
pro – expressing cells and
pcDNA3.1-expressing cells was determined by the ﬂuorescence
of SNARF-1 (Fig. 4D). Cytosolic pHi of SARS-CoV 3CL
pro –
expressing cells (pHi = 7.70 ± 0.002) was signiﬁcantly lower (t
test, P < 0.05) than that of pcDNA3.1-expressing cells
(pHi = 7.79 ± 0.009).4. Discussion
V-ATPase G subunit 1 was identiﬁed as a SARS-CoV
3CLpro-interacting protein by the aﬃnity selection of a
phage-displayed human lung cDNA library (Fig. 1). Co-
immunoprecipitation analysis and direct binding aﬃnity dem-
onstrated the speciﬁc interaction of 3CLpro with V-ATPase G
subunit 1 (Figs. 2 and 4). V-ATPase resides on the membranes
of acidic organelles such as secretary granules, lysosomes, and
the trans-Golgi network, being the major proton-extruding
molecule for maintaining acidic environment [21–25]. V-
ATPase is a multisubunit complex with two functional
domains, namely, the peripheral V1 domain and the integral
V0 domain. V-ATPase G subunit 1 belongs to the accessory
V1 subunits, being responsible for ATP hydrolysis. Interest-
ingly, human papillomavirus 16 (HPV16) E5 protein has been
demonstrated to bind to the 16-kDa subunit of the vacuolar
H(+)-ATPase (16 K) [26], and to inhibit the assembly, stability
and complex formation of the V-ATPase [27]. Our ﬁndings are
in agreement with the previous reports [26,27] showing that3CLpro protease. The SARS-CoV 3CLpro protease was incubated with
in 100 mM Tris–HCl, (pH 9.0) at 37 C, and the proteolytic processing
otein markers.
Fig. 4. Cell-based co-immunoprecipitation (A–C) and decrease intracellular pH (D) by SARS-CoV 3CLpro protease. The cell lysates of 3CLpro-
expressing cells and mock cells were immunoprecipitated by anti-His tag to 3CLpro. The immunoprecipitate was analyzed using Coomassie blue
staining (A), and Western blotting with anti-His tag antibody to 3CLpro (B) and chicken anti-V-ATPase G1 polyclonal antibody (C). In addition, the
3CLpro-expressing cells and mock cells were incubated with 20 lM carboxy SNARF-1 for 30 min at room temperature. A dual-emission ration at 580
and 640 nm of intracellular dye was detected using a ﬁxed excitation at 514 nm, and then converted to intracellular pH (D).
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pathogenesis.
Cleavage of the V-ATPase G1 fusion protein by SARS-CoV
3CLpro was found in this study (Fig. 3), implying that 3CLpro
potentially cleaves the cellular V-ATPase G1, and aﬀects the
function of vacuolar H(+)-ATPase. Meanwhile, a signiﬁcantintracellular acidiﬁcation has been demonstrated in the
3CLpro-expressing cells (Fig. 4D). The result correlated well
with previous reports in that V-ATPase-speciﬁc inhibitors
cause acidic pHi [28,29], and inﬂuences cell apoptosis [30,31].
Recent studies demonstrate the binding interaction of V-ATP-
ase with F-actin, being important for regulating in response to
6094 C.-W. Lin et al. / FEBS Letters 579 (2005) 6089–6094phosphatidylinositol 3-kinase activity [32]. Comparing to the
immunoprecipitate of mock cell extract by anti-His tag
antibody (Fig. 4A, lane 3), signiﬁcantly more proteins were
precipitated in the 3CLpro-expressing cells (Fig. 4A, lane 6),
in which some proteins such as F-actin could be brought down
by V- ATPase G1.
In conclusion, a phage displayed library encoding sequences
from human lung cDNA was used to identify potential
3CLpro-interacting lung proteins. V-ATPase G1 was identiﬁed
as a 3CLpro-interacting protein in this study. The interaction of
3CLpro with V-ATPase G1 resulted in the cleavage of V-
ATPase G1. This interaction is likely to be involved in the
virus-induced pathogenesis.
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